Analysis

High Court Plavix Ruling To Shrink, Scatter Mass Torts

Law360, New York (June 19, 2017, 10:24 PM EDT) -- The U.S. Supreme Court's decision that almost 600 non-Californians can't pursue claims in that state alleging that they were harmed by Bristol-Myers Squibb Co.'s blood thinner Plavix will likely reshape national mass tort litigation, as consumers will have fewer choices on where to file suit.

Almost unanimously, the Supreme Court found that California state courts don't have jurisdiction over outsiders' suits, reversing a decision by the state's high court that given the drugmaker's business ties to the state, California courts could exercise personal specific jurisdiction over their claims. Now, consumers will either have to pursue their claims in their home state or...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!